Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

1(50.0%)

Phase 2

1(50.0%)

2Total

N/A(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05627583Completed

Nutritional Rehabilitation and Markers of Severity in Anorexia Nervosa

Role: collaborator

NCT06755658Active Not Recruiting

RDW, Platelet Kinetics and Survival Outcome in Covid-19 Hospitalized Patients.

Role: lead

NCT05593783Unknown

The Use of the "Comprehensive Complication Index" for Urinary Lithiasis Surgery.

Role: lead

NCT05566405Not ApplicableCompleted

The Effects of Method of Anaesthesia on the Safety and Effectiveness of Radical Retropubic Prostatectomy

Role: lead

NCT04344951Phase 2Terminated

Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial

Role: collaborator

NCT04695587Unknown

The Role of Sympathetic Tone Regarding the Anatomical and Functional Recovery of the Left Ventricle in TakoTsubo Syndrome

Role: collaborator

NCT04681612Unknown

The Prognostic Role of Indices of Sympathetic Nervous System Overdrive in MINOCA

Role: collaborator

NCT03771365Unknown

Standard-PCNL vs Mini-PCNL vs Super-mini PCNL for the Treatment of ≥2 cm Renal Stone

Role: collaborator

All 8 trials loaded